StockData
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31

Minerva Neurosciences, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.32−0.03 (-1.28%)

Close on Oct 19, 2026

Market cap
$183.52M
P/E (TTM)
–
Dividend yield
–

Minerva Neurosciences, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Minerva Neurosciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.